On-treatment markers as predictors to guide anti-EGFR MoAb treatment in metastatic colorectal cancer

来源 :2015苏浙皖赣肿瘤内科治疗进展高峰论坛暨江苏省第七次肿瘤化疗与生物治疗学术会议 | 被引量 : 0次 | 上传用户:lhcllk
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
We conducted a meta-analysis to assess whether ETS and ST can guide anti-EGFR MoAb treatment in metastatic colorectal cancer (mCRC) patients.The correlation of ST and ETS with benefit acquired from additional anti-EGFR treatment and the correlation of ST with quality of life.Pooled Hazard ratio (HR) and rate difference (RD) were all estimated by using random-effects model.Pooled data from 28 studies with 5060 patients revealed that the occurrence of ST and a cut-off value of ETS≥20% (v<20%) during anti-EGFR MoAb treatment were both associated with longer OS, PFS and ORR.Similarity, relevant evidences also suggested that only wild-KRAS patients with ETS could benefit from additional anti-EGFR treatment, and the more early shrinkage the tumor was, the more benefit degree was observed.These data confirmed the prognostic role of ETS and ST in mCRC patients and these two on-treatment markers are predictive of benefit acquired from anti-EGFR treatment in wild-KRAS tumors.
其他文献
本研究开发了一种基于流式细胞术的肿瘤-血小板粘附检测技术,并采用该技术检测了抗肿瘤药物斑蝥素对乳腺癌细胞粘附血小板能力的影响.
本研究拟探讨β-catenin通路抑制剂FH535对胰腺癌细胞及裸鼠移植瘤生长的影响,从而研究β-catenin通路靶向治疗措施在胰腺癌治疗中的应用价值.结果表明FH535能够下调细胞核中β-catenin蛋白水平。FH535抑制胰腺癌细胞的生长及克隆形成能力,并抑制裸鼠移植瘤的生长。流式细胞术证实FH535能够阻滞细胞周期于G2/M期。基因芯片显示,FH535处理后,参与细胞周期调控的BCCIP
本研究拟探讨斑蝥素能否通过抑制β-catenin通路,抑制胰腺癌细胞的迁移.结果表明斑蝥素处理后,胰腺癌细胞中β-catenin磷酸化水平升高,总蛋白水平降低。斑蝥素抑制胰腺癌细胞迁移,呈剂量依赖性。FH535能够削弱斑蝥素对细胞迁移的抑制作用。基因芯片显示,FH535、斑蝥素均可抑制β-catenin信号通路下游的迁移相关基因VEGFB,NRP1、KRT8的表达。
基质金属蛋白酶2(MMP2)是参与肿瘤侵袭转移的关键基因.本研究拟探讨PP2A抑制剂对MMP2表达的调控及分子机制.证实PP2A抑制剂通过mRNA脱腺苷化信号通路依赖性机制,促进MMP2 mRNA降解,从而抑制MMP2表达。
斑蝥素处理后,胰腺癌细胞核中β-catenin水平降低。FH535能够削弱斑蝥素对细胞生长的抑制作用。基因芯片显示,FH535,斑蝥素均可抑制β-catenin信号通路下游的细胞增殖相关基因Dkk3,Cacnalg,WISP2的表达。FH535能够削弱斑蝥素对Dkk3,Cacnalg,WISP2表达的抑制作用。表明斑蝥素抑制胰腺癌细胞β-catenin通路,并通过β-catenin通路依赖性机制下
研究RUNX3基因对前列腺癌的发生与迁移的影响,并探讨其分子作用机制.结果显示相较于癌旁组织,RUNX3在前列腺癌组织中异常低表达,且与肿瘤分级有关。过表达RUNX3会上调TIMP-2、抑制MMP-2的表达与激活,从而抑制前列腺肿瘤细胞的迁移与侵袭。在前列腺细胞中抑制RUNX3表达会破坏TIMP-2和MMP-2之间的平衡,沉默TIMP-2会抑制MMP-2的表达。恢复RUNX3表达会降低VEGF的分
目的:研究人类相关转录因子3(human runt-related transcription factor3,RUNX3)在乳腺癌组织中的表达水平及其临床病理意义.方法:应用组织芯片和免疫组化的方法评估RUNX3在256例乳腺癌组织中的表达水平,并通过统计学分析其与临床病理特征及患者预后的关系.结果:在256例乳腺癌组织中RUNX3阳性表达率和阴性率分别为32%(83/256)和68%(173/
To elucidate the role of SPAG9 in the development of human prostate cancer (PCa), tissue microarray (TMA) and immunohistochemistry were used to detect the clinical relevance of SPAG9 in PCa tissues.We
会议
Curcumin is a component of turmeric, the yellow spice derived from the rhizome of Curcuma longa.It has been demonstrated to modulate multiple cell signaling pathways, including apoptosis, proliferatio
会议
乳腺癌(BC)和卵巢癌(OC)是表现为家族聚集倾向的常见女性恶性肿瘤,罹患相应肿瘤家族史是二者最重要的危险因素,表明遗传因素在BC和OC发病中的重要意义.遗传性乳腺癌-卵巢癌综合征(HBOC),是BC和OC中最常见的遗传性癌.HBOC是指一个家族中有2个一级亲属或1个一级亲属和1个二级亲属患乳腺癌或卵巢癌,并具有遗传倾向.对于BC和OC而言,HBOC无疑是良好的研究模型.由于该综合征具有显性遗传特